Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | GRK5 | P34947 | 1/20 | 0.33 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.33 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.33 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26551852 | 0.90 | CYP11B1 (0.35) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26565209 | 0.90 | GRK5 (0.35) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26551859 | 0.88 | PRKDC (0.34) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26555273 | 0.87 | GRK5 (0.33) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26565144 | 0.86 | ALOX5 (0.41) | PRKDCGRK5CYP11B1CYP11B2PTPN1 | |
| SCHEMBL26565189 | 0.86 | PGR (0.36) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26548263 | 0.86 | L3MBTL1 (0.39) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26551848 | 0.86 | SYK (0.35) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26555289 | 0.85 | PRKDC (0.34) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 | |
| SCHEMBL26548272 | 0.85 | PIK3CA (0.34) | PRKDCGRK5PIK3C2APIK3C2BPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | PRKDC 2422/4885GRK5 4717/4885PIK3C2A 4541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.